UMC119-01
/ Xuanjie
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 07, 2022
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
(clinicaltrials.gov)
- P1 | N=9 | Recruiting | Sponsor: Meridigen Biotech Co., Ltd. | Active, not recruiting ➔ Recruiting | Trial completion date: Jul 2025 ➔ Jul 2027 | Trial primary completion date: Dec 2022 ➔ Dec 2025
Enrollment open • Trial completion date • Trial primary completion date • Bronchopulmonary Dysplasia • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1